Liu Ming Hui Reports Major Stock Transactions for EnerSyn
Liu Ming Hui discloses significant stock transactions involving EnerSyn Global Inc., reflecting strategic ownership changes in the wholesale-drugs sector.
Lichty Paul Robert Files Schedule 13D for Forge Nano Holdings
Lichty Paul Robert reveals 7.5% ownership in Forge Nano Holdings, following its merger, indicating potential strategic influence within the company.
Fivespan Partners GP reports stock acquisition by Haggart
Dylan G. Haggart of Fivespan Partners GP increases his stake in Stride, Inc., signaling confidence in the educational services sector.
FOXO Technologies to Acquire Controlling Interest in Ludwig
FOXO Technologies plans to acquire a controlling stake in Ludwig Enterprises, signaling potential shifts in the medical laboratory services industry.
Aspen Neuroscience reports key ownership changes post-IPO
Aspen Neuroscience reveals significant ownership changes after its IPO, with OrbiMed Advisors and OrbiMed Capital acquiring major stakes.
Aspen Neuroscience's Boerneke Reports Stock Option Grant
Jeffrey Lee Boerneke of Aspen Neuroscience has reported a stock option grant, emphasizing the company's strategy to retain key talent in the competitive pharmaceutical industry.
Kim Vyacheslav Reports Multiple Share Transactions for Kaspi.kz
Kim Vyacheslav disclosed several transactions involving shares of Joint Stock Co Kaspi.kz, reflecting active trading by a significant shareholder.
Alpha Modus Holdings Reports Significant Shareholding Change
Alpha Modus Holdings, Inc. reveals major shareholding changes in recent SEC filing, indicating shifts in ownership dynamics within the patent leasing industry.
Matson CEO Matthew J. Cox Reports Stock Sales in SEC Filing
Matthew J. Cox, CEO of Matson, Inc., sold shares on October 29, 2026, as reported in a recent SEC filing, raising questions about future company strategies.
Aspen Neuroscience reports key ownership changes in filing
Aspen Neuroscience's recent SEC filing highlights ownership changes that could impact its market position in the pharmaceutical sector.
Aspen Neuroscience sees key ownership changes in SEC filing
Aspen Neuroscience, Inc. reveals significant ownership changes in its latest SEC filing, indicating increased investor confidence in the pharmaceutical sector.
Aspen Neuroscience reports ownership changes in SEC filing
Aspen Neuroscience, Inc. discloses ownership changes by Executive Chair Hasnain Faheem, highlighting the company's developments in pharmaceutical preparations.
Aspen Neuroscience reports new ownership changes in SEC filing
Aspen Neuroscience reveals new ownership changes, enhancing director Daniel Thomas O's stake in the company, indicating growth in the pharmaceutical sector.
HealthStream Executive Trisha Coady Reports Stock Transactions
Trisha L. Coady of HealthStream Inc reports stock transactions in an SEC filing, reflecting ongoing confidence in the company's future.
Aspen Neuroscience reveals new ownership details in filing
Aspen Neuroscience, Inc. has disclosed new ownership details in its latest SEC filing, highlighting growth in the pharmaceutical preparations sector.
Collier Michael Manning Reports Stock Transactions on Oct. 29
Collier Michael Manning discloses stock and restricted share unit transactions, reflecting ongoing commitment to HealthStream Inc. and industry trends.
Frist Acquires Shares in HealthStream Amid Ongoing Growth
Robert A. Frist Jr. acquires shares in HealthStream, signaling confidence in the company's future and impacting the business services sector.
HealthStream CTO Jeff Cunningham Reports Stock Transactions
Jeff Cunningham, CTO of HealthStream Inc., reported stock transactions in an SEC filing, reflecting his ongoing commitment to the company's equity.
Aspen Neuroscience reports director change in SEC filing
Aspen Neuroscience, Inc. announces a new director, Douglas Carl Fisher, in a recent SEC filing, signaling potential shifts in company strategy.
Aspen Neuroscience reports ownership changes by director
Aspen Neuroscience, Inc. announces ownership changes by director Damien McDevitt, signaling potential shifts in management and strategy.